|
Market Cap (19-May) $54,392,152 (781st) |
Close (30-Jun) $0.250 |
Volume (30-Jun) 84,565 |
Shortsold (5-May) 9,746 (0.00%) (586th) |
|
52w High $0.59 |
52w Low $0.083 |
P/E 8.00 |
EPS -0.01 |
MDR released this announcement to the ASX on 18 February 2022, 10:46. The announcement is marked as price sensitive, and is 2 page(s) in length and 106.45kb in size.
You can view all announcements from MDR and see how they appear on a price chart on the announcements page.
At the date of this announcement, MDR was 0.168% short sold according to ASIC data. It was ranked the 428th most shorted stock on the ASX. It remains ranked 586th as of the latest reported data (05 May 2025).
| Other Recent Announcements from MDR | |
|---|---|
| MDR undertakes strategic review | 22 June 2023, 9:51 |
| Initial Director's Interest Notice - Kate Hill | 29 May 2023, 11:05 |
| Initial Director's Interest Notice - Brett Magun | 29 May 2023, 11:00 |
| MDR enters NZ market via agreement with Green Cross Health | 18 February 2022, 10:46 |
| Appendix 3X - RaeAnn Grossman | 1 February 2022, 10:50 |
| Appointment of director | 1 February 2022, 10:40 |
| Quarterly Report and Appendix 4C | 28 January 2022, 9:53 |
You must be logged in to post a reply.
MedAdvisor 